Title:
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GSK-3 GENES
Document Type and Number:
WIPO Patent Application WO/2010/006342
Kind Code:
A9
Abstract:
The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting Glycogen Synthase Kinase-3 (GSK-3), and methods of using the dsRNA to inhibit expression of GSK-3.
Inventors:
SAH DINAH WEN-YEE (US)
HINKLE GREGORY (US)
HINKLE GREGORY (US)
Application Number:
PCT/US2009/050432
Publication Date:
December 16, 2010
Filing Date:
July 13, 2009
Export Citation:
Assignee:
ALNYLAM PHARMACEUTICALS INC (US)
SAH DINAH WEN-YEE (US)
HINKLE GREGORY (US)
SAH DINAH WEN-YEE (US)
HINKLE GREGORY (US)
International Classes:
A61K31/7088; C07H21/04; C12N5/10; C12N15/113; C12N15/63
Attorney, Agent or Firm:
SHUSTER, Michael, J. et al. (Silicon Valley Center801 California Stree, Mountain View CA, US)
Download PDF:
Previous Patent: APPARATUS AND METHODS FOR MINIMALLY INVASIVE OBESITY TREATMENT
Next Patent: GLYCOPEPTIDE CONSTRUCTS AND USES THEREOF
Next Patent: GLYCOPEPTIDE CONSTRUCTS AND USES THEREOF